Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.86B |
| 2 |
Exxon Mobil
XOM
|
+$1.35B |
| 3 |
Apple
AAPL
|
+$1.19B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Amazon
AMZN
|
+$1.06B |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.24B |
| 2 |
GE Aerospace
GE
|
+$712M |
| 3 |
Broadcom
AVGO
|
+$499M |
| 4 |
Apollo Global Management
APO
|
+$286M |
| 5 |
Super Micro Computer
SMCI
|
+$243M |
Sector Composition
| 1 | Technology | 31.9% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 11.66% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Communication Services | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
PAR Technology
PAR
$1.86B
| $34.7M | ﹤0.01% |
737,484
+131,580
| +22% | +$6.2M |
|
1602
Premier
PINC
$2.21B
| $34.7M | ﹤0.01% |
1,859,795
-118,587
| -6% | -$2.21M |
|
1603
Knowles
KN
$1.91B
| $34.7M | ﹤0.01% |
2,010,957
+72,923
| +4% | +$1.26M |
|
1604
National Beverage
FIZZ
$3.78B
| $34.7M | ﹤0.01% |
677,388
+34,951
| +5% | +$1.79M |
|
1605
Dynavax Technologies
DVAX
$1.14B
| $34.7M | ﹤0.01% |
3,089,690
+174,997
| +6% | +$1.97M |
|
1606
AST SpaceMobile
ASTS
$10.3B
| $34.7M | ﹤0.01% |
2,985,317
+314,130
| +12% | +$3.65M |
|
1607
Brookfield Renewable
BEPC
$6.09B
| $34.6M | ﹤0.01% |
1,224,308
+32,461
| +3% | +$917K |
|
1608
Fortrea Holdings
FTRE
$929M
| $34.6M | ﹤0.01% |
1,481,721
+95,936
| +7% | +$2.24M |
|
1609
Delek US
DK
$1.72B
| $34.6M | ﹤0.01% |
1,395,799
+41,194
| +3% | +$1.02M |
|
1610
Rocket Pharmaceuticals
RCKT
$354M
| $34.5M | ﹤0.01% |
1,603,610
+101,023
| +7% | +$2.18M |
|
1611
10x Genomics
TXG
$1.63B
| $34.5M | ﹤0.01% |
1,772,933
+129,780
| +8% | +$2.52M |
|
1612
Mercury Systems
MRCY
$4.38B
| $34.4M | ﹤0.01% |
1,274,959
+405,304
| +47% | +$10.9M |
|
1613
Newmark Group
NMRK
$3.4B
| $34.4M | ﹤0.01% |
3,363,893
+161,572
| +5% | +$1.65M |
|
|
JWN
1614
DELISTED
Nordstrom
JWN
| $34.4M | ﹤0.01% |
1,620,209
-30,230
| -2% | -$642K |
|
1615
Westamerica Bancorp
WABC
$1.26B
| $34.3M | ﹤0.01% |
706,537
+45,493
| +7% | +$2.21M |
|
1616
Futu Holdings
FUTU
$25.9B
| $34.3M | ﹤0.01% |
528,436
+30,809
| +6% | +$2M |
|
1617
Ligand Pharmaceuticals
LGND
$3.26B
| $34.2M | ﹤0.01% |
405,775
+24,805
| +7% | +$2.09M |
|
1618
Ingevity
NGVT
$2.14B
| $34.2M | ﹤0.01% |
781,688
+21,050
| +3% | +$920K |
|
1619
Donnelley Financial Solutions
DFIN
$1.54B
| $34.1M | ﹤0.01% |
572,587
+36,934
| +7% | +$2.2M |
|
1620
Avis
CAR
$5.53B
| $34.1M | ﹤0.01% |
326,600
-3,107
| -0.9% | -$325K |
|
1621
Virtus Investment Partners
VRTS
$1.36B
| $34M | ﹤0.01% |
150,507
+1,796
| +1% | +$406K |
|
1622
PROG Holdings
PRG
$1.44B
| $33.9M | ﹤0.01% |
976,198
+2,251
| +0.2% | +$78.1K |
|
1623
NETSCOUT
NTCT
$1.85B
| $33.8M | ﹤0.01% |
1,848,397
+111,546
| +6% | +$2.04M |
|
|
GTY
1624
Getty Realty Corp
GTY
$1.61B
| $33.7M | ﹤0.01% |
1,263,398
+69,834
| +6% | +$1.86M |
|
1625
Telus
TU
$24.4B
| $33.6M | ﹤0.01% |
2,157,707
+66,885
| +3% | +$1.04M |
|